tPA (Q38) Peptide

Cat no: BS2890P

Supplier: Bioworld Technology, Inc.

0 reviews | Write a Review Pencil

Description
Additional Information

The human urokinase-type plasminogen activator receptor (uPAR) is a 55-65 kDa, highly glycosylated, GPI-anchored cell surface receptor (the deglycosylated protein is 35 kDa). It is a central player in the plasminogen activation pathway. uPAR binds with high affinity to a serine protease urokinase-type plasminogen activator (uPA) and converts plasminogen to its active form plasmin in a spatially restricted manner on the cell surface. Plasmin further carries out the activation of uPA, which is inhibited by serpins, such as plasminogen activator inhibitors. Therefore, uPAR plays a key role in regulating extracellular proteolysis. In addition, uPAR plays an important role in regulating cell proliferation, adhesion, and mobility. Research studies have shown that overexpression of uPAR is found in various cancer cells and tissues.

Catalogue number:	BS2890P
Applications:	Block/Neutralize/Inhibit
Swiss prot:	P00750
Form:	1 mg/ml in DI water.
Purity:	Synthetic peptide tPA (Q38). (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage temp:	Store at 4 degree C short term. Aliquot and store at -20 degree C long term. Avoid freeze-thaw cycles.
Alternative names:	Tissue-type plasminogen activator; t-PA; t-plasminogen activator; tPA; EC=3.4.21.68; Alteplase; Reteplase; PLAT
Additional info:	This peptide can be used with studies using BS2890 tPA (Q38) pAb.

See Full Product Listings >

tPA (Q38) Peptide

Cat no: BS2890P

Get Quote

About Biosave

Product Categories

Information


Get a Quote Direct from Bioworld Technology, Inc.




By submitting this form you agree to your details being passed to Bioworld Technology, Inc. for the purpose of generating the best quote*